DEA Proposes New Hemp and CBD Rules to Comply With the Farm Bill
The US’s Drug Enforcement Administration (DEA) has formally suggested some amendments to the country’s Controlled Substances Act (CSA).
These changes, if implemented, would help bring written hemp and CBD rules in line with active regulations following the enactment of the 2018 Farm Bill.
Filed on August 21, the new proposal, say the DEA, “merely conforms DEA’s regulations to the statutory amendments to the CSA that have already taken effect, and it does not add additional requirements to the regulations.”
The main four proposals are:
- New wording should be included which states that “tetrahydrocannabinol” (THC) does not include “any material, compound, mixture, or preparation that falls within the definition of hemp.”
- Every CBD product that has been approved by the US Food and Drug Administration (FDA) and contains less than 0.1 percent THC should be stripped of its Schedule V status.
- Current import and export permits for hemp and its derivatives should no longer be required.
- The definition of “marihuana extract” should exclude substances that contain less than 0.3 percent THC on a dry-weight basis.
The amendments are open to public comment until October 20.
Earlier this year, the DEA removed the CBD-based medication Epidiolex from the FDA’s list of controlled substances – a decision seemingly in accordance with the new amendments.